Suppression of the entire KRAS network by MIR143#12 showed stronger anticancer activity in KRAS mutant colorectal cancer cell lines than suppression of individual genes in the KRAS network, such as KRAS, AKT, and ERK. This evidence concerns the gene AKT1 and colorectal cancer.